Fierce Healthcare September 29, 2023
Anastassia Gliadkovskaya

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers.

Oral Health Pro with CancerDetect can detect biomarkers associated with oral and throat cancers with a specificity of 95% and sensitivity of 90%, according to clinical validation data recently published by the company. A highly sensitive test means there are few false negatives, while a highly specific test means there are few false positives.

The test is “the most advanced oral and throat cancer screening test available” on the market, per Viome. Patients 50 years or older, or 18 and older who use or have used tobacco products, are eligible for the test.

The vast majority...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
Biotech venture firms continue ‘recalibration’ in third quarter, Pitchbook report finds
Forbes names 30 under 30 in healthcare
Insilico Medicine Launches First-in-Human Trial for AI-Discovered IBD Drug
How to Choose the Right Distribution Partner
Listen: CRISPR history, biotech struggles, & a big week for deals

Share This Article